- Conditions
- Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
- Locations
-
- GC2202 Study Site 115 Huntington Park, California, United States
- GC2202 Study Site 103 St. Petersburg, Florida, United States
- GC2202 Study Site 111 Bethesda, Maryland, United States
- GC2202 Study Site 109 Greenville, North Carolina, United States
Clinical trial condition
Multiple Myleoma
Explore clinical trials studying Multiple Myleoma. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Multiple Myleoma trial results
Recruiting
GR1803 Injection in Patients With RRMM
NCT06952075
- Conditions
- Multiple Myleoma
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma
NCT06880601
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
Not specified
Completed
Study of Lymphoma in Asia
NCT01584141
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Hexi District, China
- West China Hospital of Sichuan University Sichuan, China
- Queen Mary Hospital Sai Ying Pun, Hong Kong
- Buddhis Dalin Tzu Chi General Hospital Dalin Town, Taiwan